Skip to Content
  • Previous Rank
  • Revenues ($M)
  • Revenue Percent Change
  • Profits ($M)
  • Profits Percent Change
  • Assets ($M)
  • Employees
  • Market Value — as of March 31, 2017 ($M)

McKesson, the largest U.S. pharmaceutical distributor, continues to face obstacles as the tailwind from branded drug price inflation subsides and customers look elsewhere. But its management isn’t taking the news lying down. A series of acquisitions, ongoing restructuring, and a rash of new deals are helping lessen the blow, setting in motion a roller-coaster ride of a year. McKesson was founded in 1833 and is headquartered in San Francisco.

Created with sketchtool.Created with sketchtool.Looking for leads, investment insights, or competitive intelligence?Buy Now

Company Info

John H. Hammergren
CEO Title
Chairman, President & Chief Executive Officer
Wholesalers: Health Care
HQ Location
San Francisco, CA
Years on Fortune 500 List23
Figures are for fiscal year ended March 31, 2016.

McKesson Rank History


Key Financials (Last Fiscal Year)

$ millions% change
Revenues ($M)$192,4876.2%
Profits ($M)$2,25853%
Assets ($M)$56,563-
Total Stockholder Equity ($M)$8,924-
Market Value — as of March 31, 2017 ($M)$31,439-

Profit Ratios

Profit as % of Revenues1.2%
Profits as % of Assets4%
Profits as % of Stockholder Equity25.3%

Earnings Per Share (Last Fiscal Year)

Earnings Per Share ($)9.7
EPS % Change (from 2015)54.7%
EPS % Change (5 year annual rate)16.2%
EPS % Change (10 year annual rate)15.1%

Total Return

Total Return to Investors (2016)-28.3%
Total Return to Investors (5 year, annualized)13.3%
Total Return to Investors (10 year, annualized)11.6%